Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Liminal BioSciences Inc. PFSCF


Primary Symbol: LMNL

Liminal BioSciences is a biopharmaceutical company focused on the discovery and development of novel, small molecule drug candidates for the treatment of patients suffering from fibrotic or inflammatory diseases that have a high unmet medical need. Liminal BioSciences operates on an integrated basis from our talent hubs in Laval, Quebec, Canada, and Cambridge, UK. Our common shares are listed for trading on the Nasdaq Global Market.


NDAQ:LMNL - Post by User

Bullboard Posts
Comment by barcodewhizon Jan 06, 2005 5:17pm
109 Views
Post# 8397108

RE: nice start eom

RE: nice start eomStoocks... I think what we saw in the last large volume move up was funds like Acuity and others buying back in.... I dont know how much true new blood there was. Frankly I think there's been a bunch of new RETAIL interest generated by word of mouth and better news flow... I still think we're grossly lacking a solid analyst covering the story that understands the science and the magnitude of the opportunity. Its well founded balanced coverage that will help instill confidence in potential institutional buyers as will a solid focussed effort by IR and Pierre. I know you harp on the cash flow side and I do agree to some extent. However, if the company can get the market to respect the business that's in the pipleline and the value of the franchise, then that just simply should be a worry because bridge $$ will always be available either thru JV's, licensing or even selling all or part of a successful division and ultimately the business itself will be a cash cow.
Bullboard Posts